ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Sana Biotechnology, IASO Biotherapeutics, and Innovent Biologics Announce Non-Exclusive License Agreement for Clinically Validated BCMA CAR Construct
January 11, 2022Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on creating and delivering engineered cells as medicines, IASO Biotherapeutics ("IASO Bio"), a clinical-stage biopharmaceutical company engaged in discovering... -
IASO Biotheraputics' CT120 Granted Orphan Drug Designation by the U.S. FDA
November 26, 2021IASO Biotherapeutics (IASO Bio), a clinical-stage biopharmaceutical company focusing on discovering, developing, and manufacturing innovative medicine announced on Oct 26, 2021 that the Office of Orphan Products Development...
Pharma Sources Insight January 2025
